Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) EBIT per Share : ¥0.42 (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi C&Y Pharmaceutical Group Co EBIT per Share?

Shanxi C&Y Pharmaceutical Group Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.13. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.42.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Shanxi C&Y Pharmaceutical Group Co's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shanxi C&Y Pharmaceutical Group Co was 36.60% per year. The lowest was -24.40% per year. And the median was -7.05% per year.

SZSE:300254's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Shanxi C&Y Pharmaceutical Group Co's EBIT for the three months ended in Mar. 2024 was ¥30.2 Mil.

Shanxi C&Y Pharmaceutical Group Co EBIT per Share Historical Data

The historical data trend for Shanxi C&Y Pharmaceutical Group Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi C&Y Pharmaceutical Group Co EBIT per Share Chart

Shanxi C&Y Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.10

-1.14

-0.07

-0.19

0.37

Shanxi C&Y Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.07	-0.03	0.09	0.24	0.13

Shanxi C&Y Pharmaceutical Group Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Shanxi C&Y Pharmaceutical Group Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	88.438	/	241.568
=	0.37

Shanxi C&Y Pharmaceutical Group Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	30.158	/	241.537
=	0.12

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.42

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Shanxi C&Y Pharmaceutical Group Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Shanxi C&Y Pharmaceutical Group Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi C&Y Pharmaceutical Group Co Ltd (SZSE:300254) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No.53, Hubin Street, Economic and Technological Development Zone, Datong, CHN, 037010

Website

http://www.cy-pharm.com

Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.

Executives

Zuo Xue Min	Supervisors
Huang Le Qun	Director
Zhang Zhen Biao	Executives
Yu Jun Xian	Directors, Directors, and Executives
Zhao Qun	Director
Weng Zhan Guo	Director
Geng Chun Feng	Director
Pang Xiao Quan	Supervisors
Zhong Hai Rong	Directors, executives
Xuan Hang	Director

Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Headlines

No Headlines